An Analytical Reference Standard
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

3,4-Dihydroxyamphetamine (hydrochloride)

Item No. 30531

Synonyms
Synonyms
  • DHA
  • α-Methyldopamine
  • α-MeDA
Technical Information
Formal Name
4-(2-aminopropyl)-1,2-benzenediol, monohydrochloride
CAS Number
828-06-8
Molecular Formula
C9H13NO2 • HCl
Formula Weight
Purity
≥98%
Formulation
A crystalline solid
DMF: 10 mg/mlDMSO: 10 mg/mlEthanol: 5 mg/mlPBS (pH 7.2): 10 mg/ml
SMILES
OC1=CC=C(CC(N)C)C=C1O.Cl
InChi Code
InChI=1S/C9H13NO2.ClH/c1-6(10)4-7-2-3-8(11)9(12)5-7;/h2-3,5-6,11-12H,4,10H2,1H3;1H
InChi Key
MCRAZJGRCJLDOI-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Cayman Chemical
    Cayman Spectral Library

    Our free, searchable, GC-MS spectral database contains 70eV EI mass spectral data of 2,000+ of Cayman’s forensic drug standards.

    DOWNLOAD THE DATABASE
    Product Description

    3,4-Dihydroxyamphetamine (hydrochloride) (Item No. 30531) is an analytical reference standard categorized as an amphetamine. 3,4-Dihydroxyamphetamine is a metabolite of 3,4-MDMA (Item Nos. ISO60190 | 13971) via the intermediate (±)-MDA (Item Nos. ISO60189 | 11554).1,2 This product is intended for research and forensic applications.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Schwaninger, A.E., Meyer, M.R., Barnes, A.J., et alUrinary excretion kinetics of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) and its phase I and phase II metabolites in humans following controlled MDMA administration. Clin. Chem. 57(12), 1748-1756 (2011).

    2. Carvalho, M., Hawksworth, G., Milhazes, N., et alRole of metabolites in MDMA (ecstasy)-induced nephrotoxicity: An in vitro study using rat and human renal proximal tubular cells. Arch. Toxicol. 76(10), 581-588 (2002).